NEW YORK (GenomeWeb) – Atlas Genetics announced today that it has received  a two-year phase II contract from Innovate UK worth £2 million ($2.6 million), to expand its sexually transmitted infection test menu for the io rapid diagnostic platform, and to support the introduction of the platform into UK sexual health clinics.    

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.